-
Northern Lights collaboration for better 2-photon probes
https://braincanada.ca/fr/subventions-financées/northern-lights-collaboration-for-better-2-photon-probesThe will combine the expertise of four very different investigators and laboratories from Montana and Canada with complementary interests and skills to tackle a fundamental problem in imaging of the activity of the living brain. Project Overview The will combine the expertise of four very...
-
Nouveau partenariat BD²
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/nouveau-partenariat-bd²Brain Canada and Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced an international partnership to advance research and transform care for people living with bipolar disorder. Dans le cadre de ce partenariat, BD² a également annoncé son premier site de réseau intégré...
-
Nouvelle plateforme de recherche transformatrice
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/nouvelle-plateforme-de-recherche-transformatricePHOTO : De gauche à droite : Jean-Pierre Perreault, recteur de l'Université de Sherbrooke ; Geneviève Hébert, députée de Saint-François et adjointe parlementaire au ministre délégué à l'Économie et aux Petites et Moyennes Entreprises ; Stéphanie McMahon, directrice de la coordination de la mission...
-
Nouvelle recherche sur la neurodégénérescence et l'immunologie
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/nouvelles-recherches-sur-la-neurodégénérescence-et-l-immunologieLa Fondation Brain Canada, en partenariat avec la fondation Krembil, a le plaisir d’annoncer les récipiendaires des subventions d’accélération : neurodégénérescence x immunologie, qui représentent un investissement de 3 M$ pour soutenir les travaux audacieux à des stades précoces visant à éclaircir...
-
Nouvelles et mises à jour
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jourPour chaque dollar dépensé en financement de démarrage dans le cadre du programme des futurs leaders de la recherche sur le cerveau au Canada, les futurs leaders obtiendront 7,75 dollars supplémentaires pour exploiter leurs résultats. Ouvrir de nouvelles voies, faire des percées Brain Canada...
-
Novel approaches to central nervous system white matter repair
https://braincanada.ca/fr/subventions-financées/novel-approaches-to-central-nervous-system-white-matter-repairMany nerve cells in the body are covered with a protective sheath known as myelin, which allows fast conduction of nerve impulses, and which is produced by two different types of cells called oligodendrocytes and Schwann cells. Project Overview Many nerve cells in the body are covered with a...
-
Novel approaches to early detection and treatment of ASD
https://braincanada.ca/fr/subventions-financées/novel-approaches-to-early-detection-and-treatment-of-asdMore than 1 in 100 individuals are diagnosed with Autism Spectrum Disorder (ASD), with profound impacts on the quality of life of those who are affected and their families. Project Overview More than 1 in 100 individuals are diagnosed with Autism Spectrum Disorder (ASD), with profound impacts on...
-
Novel approaches to understand the role of cAMP and co-signaling cascades in synaptic plasticity and brain disorders
https://braincanada.ca/fr/subventions-financées/novel-approaches-to-understand-the-role-of-camp-and-co-signaling-cascades-in-synaptic-plasticity-and-brain-disordersSynaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. Project Overview Synaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. It is widely believed that synaptic plasticity is...
-
Novel biological agents in the treatment of amyotrophic lateral sclerosis based on progranulin/granulin structure
https://braincanada.ca/fr/subventions-financées/novel-biological-agents-in-the-treatment-of-amyotrophic-lateral-sclerosis-based-on-progranulin-granulin-structureChallenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Project Overview Challenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Our challenge is to develop a biologic-therapy that slows,...
-
Novel biomarkers of SOD1 pathology in familial and sporadic ALS
https://braincanada.ca/fr/subventions-financées/novel-biomarkers-of-sod1-pathology-in-familial-and-sporadic-alsMutations in the SOD1 gene, leading to the misfolding and toxic aggregation of SOD1 protein, are the second leading cause of Familial Amyotrophic Lateral Sclerosis (FALS-SOD1) and emerging literature has detected misfolded SOD1 (mSOD1) in the cerebrospinal fluid (CSF) and post-mortem tissue of...